WALLINGFORD, Conn.--(BUSINESS WIRE)--Z-Medica, LLC, a leading developer and marketer of hemostatic agents, announces today that the U.S. Department of Defense’s Committee on Tactical Combat Casualty Care (CoTCCC) has recommended QuikClot Combat Gauze® as the “hemostatic dressing of choice” for tactical field care in their updated guidelines which will be published in the Journal of Special Operations Medicine. QuikClot Combat Gauze® is proudly “Made in the U.S.A.”
“Our longstanding and unwavering commitment to the US Military goes back over a decade and QuikClot Combat Gauze® has been the hemostatic dressing of choice in the Tactical Combat Casualty Guidelines since 2008,” said Z-Medica President and CEO, Stephen J. Fanning. “While other hemostatic products have been added to the new guidelines as a back-up, QuikClot Combat Gauze® continues to be the recommended first line of treatment for saving the lives of our nation’s military in the line of fire.”
The Committee on Tactical Combat Casualty Care (CoTCCC) is composed of trauma surgeons, emergency medicine physicians, combatant unit physicians, combat medics, and corpsmen. The group represents all of the U.S. armed services and has 100% deployed experience. Tactical Combat Casualty Care (TCCC) guidelines, started as a biomedical research project in the U.S. Special Operations Command (USSOCOM). TCCC was introduced as a new framework on which to build trauma care guidelines customized for the battlefield. These trauma care guidelines are customized for battlefield use and are reviewed and updated by CoTCCC on an ongoing basis.
About Z-Medica®, LLC
Z-Medica, LLC is a medical device company founded in 2002 developing fast acting, easy to use, hemostasis products that stop bleeding wherever it occurs, making it possible to save lives and improve patient outcomes. Based on tests conducted by the Naval Medical Research Center and the U.S. Army Institute for Surgical Research, the Committee on Tactical Combat Casualty Care (CoTCCC) recommended QuikClot Combat Gauze® as the hemostatic agent for the Department of Defense and for use by all U.S. military forces as the first line hemostatic agent for traumatic bleeding for compressible hemorrhage. QuikClot® products are developed and manufactured in the United States. Z-Medica, LLC is a privately-held company based in Wallingford, CT. For more information, visit www.z-medica.com.